XANTURENASE * 10CPR 300MG
Therapeutic indications
Vitamin B6 deficiency therapy and prophylaxis
Dosage and method of use
1 - 2 tablets per day.
Contraindications
Hypersensitivity already known to the components. Administration of pyridoxine should be avoided in patients using L-DOPA.
Side effects
No notable side effects have been observed in humans. Rarely, non-specific skin reactions may occur.
Special warnings
Keep out of reach of children.
Pregnancy and breastfeeding
The use of the drug is not recommended during breastfeeding.
Expiry and retention
Store at a temperature not exceeding 25 ° C.
Interactions with other drugs
The use of Xanturenase should be avoided in subjects treated with L-DOPA, due to the more rapid decarboxylation of the extracerebral amine.
Overdose
There are no known cases of overdose.
Active principles
One 455 mg tablet contains: Active ingredients: pyridoxine HCI 300 mg Excipients: corn starch 50 mg, lactose 50 mg, polyvinylpyrrolidone 30 mg, talc 20 mg, stearic acid 5 mg.
Excipients
-----